Advancing Understanding of Patient Risk Perception to Inform Vaccination Strategy

Our Challenge: A global pharmaceutical company sought a deeper understanding of how individuals perceive risk related to a vector-borne illness and how these perceptions influence vaccination intentions. Existing data lacked a clear, theory-driven explanation of which aspects of risk mattered most, limiting the ability to design effective education, research, and long-term vaccination strategies. 

Our Unique Approach: We conducted a multi-phase research program grounded in behavioral science. This included reviewing existing data, developing and validating new survey measures, and deploying original quantitative research across endemic and neighboring regions, with quantitative insights synthesized using advanced statistical modeling. We then conducted primary qualitative interviews with consumers living in U.S. endemic regions to add context and explanation to key quantitative findings, translating insights into a concise, behaviorally informed report with clear implications and next steps. 

Successful Outcomes: The work produced a validated, theory-driven framework linking risk perception to vaccination intent, enriched by real-world consumer perspectives. Findings were translated into peer-reviewed publications, conference presentations, and actionable reports, providing a durable foundation to inform future research, education, and vaccination strategy.